Cosmax BTI, Inc. (KRX:044820)

Cosmax BTI Revenue

Cosmax BTI had revenue of 238.98B KRW in the quarter ending June 30, 2026, with 45.96% growth. This brings the company's total for the last twelve months to 771.33B, up 25.12% year-over-year. In the year 2025, Cosmax BTI had annual revenue of 645.21B with 7.96% growth. That makes Cosmax BTI the 10,465th largest company in the world by revenue and 480th in South Korea.

• Revenue (ttm): 771.33B
• Revenue Growth: +25.12%
• P/S Ratio: 0.27
• Revenue / Employee: 2.07B
• Employees: 373
• Market Cap: 211.64B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Health Functional Food 455.66B 68.2%
• Other 177.73B 26.6%
• Pharmaceutical 34.97B 5.2%

By Geography

Chart

• South Korea 553.49B 82.8%
• Australia 53.41B 8.0%
• Asia 39.42B 5.9%
• USA 22.04B 3.3%

Fiscal year ended Dec 31, 2025 See the full Cosmax BTI breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	645.21B	47.58B	7.96%
Dec 31, 2024	597.63B	-30.97B	-4.93%
Dec 31, 2023	628.60B	11.19B	1.81%
Dec 31, 2022	617.40B	41.41B	7.19%
Dec 31, 2021	576.00B	50.09B	9.53%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 29, 2026

Data Sources Report a data error